Skip to main content
Fig. 5 | Egyptian Journal of Medical Human Genetics

Fig. 5

From: Momordica charantia nanoparticles potentiate insulin release and modulate antioxidant gene expression in pancreas of diabetic rats

Fig. 5

a Effects of M. charantia nanoparticles on ALT. ALT activity was determined by using the serum of diabetic rats as described in “Methods” section. Values are mean ± SEM of five experimental animals (n = 5). * represents significant difference (p < 0.05) to control, while # represents significant difference (p < 0.05) to STZ (diabetic control) group. b Effects of M. charantia nanoparticles on AST. AST activity was determined by using the serum of diabetic rats as described in “Methods” section. Values are mean ± SEM of five experimental animals (n = 5). * represents significant difference (p < 0.05) to control, while # represents significant difference (p < 0.05) to STZ (diabetic control) group. c Effects of M. charantia nanoparticles on ALP. ALP activity was determined by using the serum of diabetic rats as described in “Methods” section. Values are mean ± SEM of five experimental animals (n = 5). * represents significant difference (p < 0.05) to control, while # represents significant difference (p < 0.05) to STZ (diabetic control) group

Back to article page